Exodus Point Capital Management, LP 9 Meters Biopharma, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.33 $27,710 - $43,358	-32,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.03 - $1.41 $33,578 - $45,966	32,600 New	32,600 $42,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $308,027 - $444,270	-296,180 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $210,067 - $540,172	250,080 Added 542.47%	296,180 $347,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.11 $87,097 - $148,735	-133,996 Reduced 74.4%	46,100 $40,000
Q3 2020 Nov 16, 2020	BUY	$0.48 - $0.84 $86,446 - $151,280	180,096 New	180,096 $147,000

73.4K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.